SW
Simplicity Wealth Portfolio holdings
AUM
$2.4B
1-Year Return
17.82%
This Quarter Return
+3.67%
1 Year Return
+17.82%
3 Year Return
+54.52%
5 Year Return
–
10 Year Return
–
AUM
$4.43B
AUM Growth
+$228M
(+5.4%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
2.38%
Top 10 Holdings %
Top 10 Hldgs %
23.27%
Holding
1,317
New
140
Increased
581
Reduced
481
Closed
77
Top Buys
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$12.4M |
| 2 |
Invesco QQQ Trust
QQQ
|
$12.3M |
| 3 |
iShares Russell Top 200 Growth ETF
IWY
|
$11.3M |
| 4 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
$9.55M |
| 5 |
Vanguard Dividend Appreciation ETF
VIG
|
$8.16M |
Sector Composition
| 1 | Technology | 13.17% |
| 2 | Healthcare | 9.47% |
| 3 | Financials | 4.92% |
| 4 | Consumer Discretionary | 4.41% |
| 5 | Industrials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
SiriusXM
SIRI
$8.1B
| $50.3K | ﹤0.01% |
1,778
-389
| -18% | -$11K |
|
1202
SoundHound AI
SOUN
$5.6B
| $47.4K | ﹤0.01% |
11,990
+776
| +7% | +$3.07K |
|
1203
Glimpse Group
VRAR
$28.4M
| $46.7K | ﹤0.01% |
45,743
| – | – |
|
|
CMU
1204
MFS High Yield Municipal Trust
CMU
$84.9M
| $45.9K | ﹤0.01% |
+13,379
| New | +$45.9K |
|
|
BDN
1205
Brandywine Realty Trust
BDN
$761M
| $45.8K | ﹤0.01% |
10,223
-132
| -1% | -$591 |
|
1206
Compass
COMP
$4.89B
| $44.1K | ﹤0.01% |
12,263
-398
| -3% | -$1.43K |
|
|
TWKS
1207
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $43.6K | ﹤0.01% |
+15,348
| New | +$43.6K |
|
1208
Outdoor Holding Company Common Stock
POWW
$174M
| $43.1K | ﹤0.01% |
25,670
-1,184
| -4% | -$1.99K |
|
1209
Karyopharm Therapeutics
KPTI
$59.3M
| $42.7K | ﹤0.01% |
3,277
+343
| +12% | +$4.46K |
|
1210
SCYNEXIS
SCYX
$37.2M
| $40K | ﹤0.01% |
20,000
| – | – |
|
1211
SGHC Ltd
SGHC
$6.29B
| $39.6K | ﹤0.01% |
12,245
-1,297
| -10% | -$4.19K |
|
1212
Nokia
NOK
$24.6B
| $39.2K | ﹤0.01% |
+10,381
| New | +$39.2K |
|
1213
Design Therapeutics
DSGN
$358M
| $39K | ﹤0.01% |
11,632
+137
| +1% | +$459 |
|
1214
Fate Therapeutics
FATE
$114M
| $37.5K | ﹤0.01% |
11,419
+403
| +4% | +$1.32K |
|
1215
Esperion Therapeutics
ESPR
$528M
| $36.4K | ﹤0.01% |
16,395
| – | – |
|
1216
Accuray
ARAY
$170M
| $36.1K | ﹤0.01% |
19,833
| – | – |
|
1217
Hertz
HTZ
$1.71B
| $36.1K | ﹤0.01% |
+10,222
| New | +$36.1K |
|
1218
Cerence
CRNC
$399M
| $35.4K | ﹤0.01% |
+12,525
| New | +$35.4K |
|
1219
Crexendo
CXDO
$199M
| $34.6K | ﹤0.01% |
11,000
| – | – |
|
1220
Anixa Biosciences
ANIX
$96.3M
| $30.9K | ﹤0.01% |
13,969
| – | – |
|
1221
Grupo Aval
AVAL
$3.86B
| $30.5K | ﹤0.01% |
+13,987
| New | +$30.5K |
|
1222
Pacific Biosciences
PACB
$375M
| $28.7K | ﹤0.01% |
+20,971
| New | +$28.7K |
|
1223
Xeris Biopharma Holdings
XERS
$1.28B
| $27.4K | ﹤0.01% |
+12,156
| New | +$27.4K |
|
1224
Lyell Immunopharma
LYEL
$231M
| $26.7K | ﹤0.01% |
921
-371
| -29% | -$10.8K |
|
|
IAUX
1225
i-80 Gold Corp
IAUX
$682M
| $26.1K | ﹤0.01% |
24,155
-90,378
| -79% | -$97.6K |
|